Description

Urorek (silodosin) hard capsules 4 mg. №30

Ingredients

Each hard capsule contains 4 mg of silodosin.

Dosage

The recommended dosage is one 4 mg capsule daily, taken orally with water.

Indications

Urorek (silodosin) is indicated for the treatment of benign prostatic hyperplasia (BPH) to improve urinary symptoms.

Contraindications

Do not use Urorek if you are allergic to silodosin or if you have severe liver or kidney problems.

Directions

Take Urorek exactly as prescribed by your healthcare provider. Do not exceed the recommended dosage.

Scientific Evidence

Silodosin, the active ingredient in Urorek, is a selective alpha-1 adrenergic receptor antagonist that specifically targets the alpha-1A adrenergic receptor subtype in the prostate. By blocking these receptors, silodosin relaxes the smooth muscle in the prostate and bladder neck, leading to improved urinary flow and reduced symptoms of BPH.

Clinical trials have demonstrated the efficacy of silodosin in improving International Prostate Symptom Score (IPSS) and maximum urinary flow rate (Qmax) in patients with BPH. A study published in the Journal of Urology showed that silodosin significantly improved IPSS and Qmax compared to placebo, with a good safety profile.

Additional Information

It is important to note that Urorek may cause dizziness or fainting, especially when standing up from a sitting or lying position. Patients should be cautious when driving or operating machinery. Additionally, inform your healthcare provider about all medications you are taking before starting Urorek to avoid potential drug interactions.

Always follow your healthcare provider’s instructions and attend regular check-ups to monitor your progress while taking Urorek. If you experience any severe side effects or allergic reactions, seek medical attention immediately.